Stem Cell Research in Bipolar Disorder
The latest study for the U-M Prechter Bipolar Research Team is to establish inducible stem cells (iPS) from individuals with bipolar disorder.
The Bipolar Research Team recently launched a project entitled the Cellular and Molecular Neurobiology of Mood Disorders. The goal of this study is to establish stem cell lines from skin cells taken from individuals with bipolar disorder and study details of molecular mechanisms.
Using the very latest laboratory techniques, researchers will isolate certain skin cells (fibroblasts) from a skin biopsy sample and manipulate, or “induce” the cells to make them behave and function like neurons in the brain. These cells will be grown in test tubes to study details of how the genetic material (DNA) may be affected by factors such as the presence of medication, which could influence the functioning of the neuronal cells. Integration of the extensive clinical and physiological data from study participants along with the emerging cellular data from the stem cell research is highly likely to assist in determining why some individuals respond to specific interventions, or why stressors result in variable outcomes.
“We are very excited about studying cellular mechanisms; this technology brings us to essence of the biology of nerve cells from people with bipolar disorder,” said Melvin McInnis, M.D., the Principal Investigator of the Prechter Bipolar Research Projects.
Volunteers who would like to participate in this research must first be a participant in the Prechter Longitudinal Study of Bipolar Disorder. To learn more about participating in research, please contact a research associate at 1-877-UM GENES (1-877-864-3637) or email@example.com
Stem cell research is a rapidly advancing research field. As the National Institute of Health (NIH) website states: “Stem cells have the remarkable potential to develop into many different cell types in the body during early life and growth. In addition, in many tissues they serve as a sort of internal repair system, dividing essentially without limit to replenish other cells as long as the person or animal is still alive.” Further information about stem cell research can be found here.
You may also read more about our stem cell research here.
This study has received approval from IRBMED: HUM00043228
“We are very excited about studying cellular mechanisms; this technology brings us to essence of the biology of nerve cells from people with bipolar disorder.”
Melvin McInnis, M.D.
This research is made possible in part by the Steven M. Schwartzberg Memorial Fund.